Our paper on mechanisms of resistance crizotinib and lorlatinib in ROS1 fusion-positive lung cancer is now available in Clinical Cancer Research. A true translational team effort!
Congratulations to Hideko for receiving a Pilot Grant award from the Lung Cancer Research Foundation to study the role of APOBEC3A in evolution of acquired drug resistance!
Congratulations to Hideko for being awarded a MGH ECOR Fund for Medical Discovery Postdoctoral Fellowship Award for her work on evolution of resistance of EGFR mutant lung cancer!